THE FUTURE OF PET MEDICINE
Lifescient is a veterinary pharmaceutical company addressing the growing demand for improved treatment options for pets by reformulating daily medications into Long-Acting Injectables. LAIs will meet the need for pet specific medications and offer a supervision-free treatment option for pets.
The technical feasibility of our platform technology has been established and the proof of concept of our proprietary drug delivery platform has been demonstrated with several medications. This will enable us to address conditions across multiple therapeutic classes and species.
Lifescient is dedicated to Improving the Quality of Care for Pets With Our Innovative Long-Acting Injectable Drug Delivery Platform.
January 2024: FDA accepts Lifescient’s application to open an Investigational New Animal Drug file for LS-001.
November 2023: FDA grants Lifescient sponsor fee waiver to support the development of LS-001, an analgesic LAI for dogs.
BENEFITS OF LONG-ACTING INJECTABLES
Supervision free treatment
Guaranteed prescription compliance
Improved quality of care
Minimized side effects
Enhanced pet comfort and peace of mind to pet parents
Prevention of drug abuse and diversion